Herpes Zoster Ophthalmicus clinical trials at UCSF
1 research study open to eligible people
Showing trials for
Zoster Eye Disease Study
open to eligible people ages 18 years and up
This is a multi-center, randomized, double-masked, placebo-controlled clinical trial of suppressive valacyclovir for one year in immunocompetent study participants with an episode of dendriform epithelial keratitis, stromal keratitis, endothelial keratitis, and/or iritis due to Herpes Zoster Ophthalmicus (HZO) in the year prior to enrollment.
San Francisco, California and other locations
Our lead scientists for Herpes Zoster Ophthalmicus research studies include John Gonzales, MD.
Last updated: